Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States

Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?

(2015) Bruce K. Birmingham et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Effects of polymorphisms in ABCG2, SLCO1B1, SLC10A1 and CYP2C9/19 on plasma concentrations of rosuvastatin and lipid response in Chinese patients

(2013) Hon-Kit Lee et al.   PHARMACOGENOMICS

Understanding the Critical Disposition Pathways of Statins to Assess Drug–Drug Interaction Risk During Drug Development: It's Not Just About OATP1B1

(2012) R Elsby et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The effects of green tea polyphenols on drug metabolism

(2012) Chung S Yang et al.   Expert Opinion on Drug Metabolism & Toxicology

Transporter Pharmacogenetics and Statin Toxicity

(2009) M Niemi   CLINICAL PHARMACOLOGY & THERAPEUTICS

ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin

(2009) J E Keskitalo et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Population pharmacokinetics of rosuvastatin: implications of renal impairment, race, and dyslipidaemia

(2008) Tsang-Bin Tzeng et al.   CURRENT MEDICAL RESEARCH AND OPINION

Pharmacogenomics of MRP Transporters (ABCC1-5) and BCRP (ABCG2)

(2008) Ulrike Gradhand et al.   DRUG METABOLISM REVIEWS